Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Purchase | 2024-03-29 11:08 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 500 | $2.55 | $1,275 | 53,628 (Indirect Direct) | View |
| 2021-10-15 Purchase | 2024-03-19 3:47 pm | Rezolute Inc. | RZLT | HANDOK INC. Director 10% Owner | 3,927,126 | $4.3289 | $17,000,003 | 5,942,617 (Direct) | View |
| 2024-03-15 Purchase | 2024-03-19 09:17 am | Rezolute Inc. | RZLT | Evans Daron CFO | 20,000 | $1.6915 | $33,830 | 159,900 (Indirect Direct) | View |
| 2024-03-14 Purchase | 2024-03-18 11:20 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 10,000 | $1.88 | $18,800 | 53,128 (Indirect Direct) | View |
| 2024-03-07 Purchase(A) | 2024-03-18 11:19 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 500 | $1.85 | $925 | 43,128 (Indirect Direct) | View |
| 2022-07-22 Purchase | 2024-03-14 10:35 am | Rezolute Inc. | RZLT | Kim Young-Jin Director | 115,450 | $3.2036 | $369,858 | 6,058,067 (Indirect Direct) | View |
| 2024-03-07 Purchase | 2024-03-11 10:35 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 500 | $1.85 | $925 | 43,052 (Indirect Direct) | View |
| 2024-03-08 Purchase | 2024-03-08 12:37 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 50,000 | $1.9269 | $96,345 | 139,900 (Indirect Direct) | View |
| 2024-02-26 Purchase | 2024-02-28 11:40 am | Rezolute Inc. | RZLT | Elam Nevan C CEO | 5,000 | $1.68 | $8,400 | 7,817 (Direct) | View |
| 2024-02-23 Purchase | 2024-02-27 08:47 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 8,000 | $1.6925 | $13,540 | 42,552 (Direct) | View |
| 2024-02-16 Purchase | 2024-02-21 11:55 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 7,000 | $1.306 | $9,142 | 34,552 (Direct) | View |
| 2024-02-16 Purchase | 2024-02-20 07:01 am | Rezolute Inc. | RZLT | Evans Daron CFO | 50,900 | $1.3112 | $66,741 | 85,400 (Indirect Direct) | View |
| 2023-07-03 Purchase | 2023-07-06 11:18 am | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 5,000 | $1.8999 | $9,500 | 27,552 (Direct) | View |
| 2022-05-17 Purchase | 2022-05-19 3:13 pm | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | 1,500 | $3.2415 | $4,862 | 22,552 (Direct) | View |
| 2022-05-04 Purchase(A) | 2022-05-09 4:28 pm | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 52,631 | $3.8 | $199,998 | 53,572 (Indirect) | View |
| 2022-05-04 Purchase | 2022-05-06 5:18 pm | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | 21,052 | $3.8 | $79,998 | 21,052 (Direct) | View |
| 2022-05-04 Purchase | 2022-05-06 5:15 pm | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 52,631 | $3.8 | $199,998 | 99,673 (Indirect Direct) | View |
| 2021-10-15 Purchase | 2022-05-06 5:14 pm | Rezolute Inc. | RZLT | Hogenhuis Wladimir Director | 32,693 | $4.4353 | $145,005 | 32,693 (Direct) | View |
| 2019-07-23 Purchase | 2021-07-28 5:24 pm | Rezolute Inc. | RZLT | Genexine Inc. 10% Owner | 34,482,758 | $0.29 | $10,000,000 | 91,300,933 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Option Award | 2024-01-25 12:47 pm | N/A 2029-01-23 | Rezolute Inc. | RZLT | Evans Daron CFO | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2024-01-25 12:46 pm | N/A N/A | Rezolute Inc. | RZLT | Evans Daron CFO | 0 | $0 | 39,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:36 pm | N/A 2029-01-23 | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:33 pm | N/A 2029-01-23 | Rezolute Inc. | RZLT | Elam Nevan C CEO | 340,000 | $0 | 340,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:10 pm | N/A 2034-01-23 | Rezolute Inc. | RZLT | Hogenhuis Wladimir Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:08 pm | N/A 2034-01-23 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:06 pm | N/A 2034-01-23 | Rezolute Inc. | RZLT | FAUCHET PHILIPPE Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:04 pm | N/A 2034-01-23 | Rezolute Inc. | RZLT | KREHER NERISSA Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-28 10:15 am | N/A 2032-06-23 | Rezolute Inc. | RZLT | Kim Young-Jin Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 6:19 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | FAUCHET PHILIPPE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 6:12 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | 700,000 | $0 | 700,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 6:08 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | Hogenhuis Wladimir Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:56 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | Elam Nevan C Chief Executive Officer | 2,600,000 | $0 | 2,600,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:43 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:30 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | KREHER NERISSA Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-06-14 Disposition(A) | 2021-08-31 2:02 pm | 2015-02-23 2025-02-23 | Rezolute Inc. | RZLT | Elam Nevan C Chief Executive Officer | 204,800 | $0 | 1,250,000 (Direct) | View |
| 2021-06-14 Option Award(A) | 2021-08-31 2:02 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | Elam Nevan C Chief Executive Officer | 375,000 | $0 | 1,250,000 (Direct) | View |
| 2019-04-26 Conversion | 2021-07-28 5:24 pm | N/A N/A | Rezolute Inc. | RZLT | Genexine Inc. 10% Owner | 56,818,175 | $0 | 91,300,933 (Direct) | View |
| 2019-04-26 Conversion | 2021-07-28 5:24 pm | N/A N/A | Rezolute Inc. | RZLT | Genexine Inc. 10% Owner | 1,250,000 | $10 | 91,300,933 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:11 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | Hogenhuis Wladimir Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:08 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | FAUCHET PHILIPPE Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:05 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | KREHER NERISSA Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:03 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-06-14 Disposition | 2021-07-14 9:00 pm | 2017-04-13 2027-04-13 | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | 29,000 | $0 | 75,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:00 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | 75,000 | $0 | 75,000 (Direct) | View |